Matthew R. Weir, M.D. Page 13 of 51, 4/7/2010
16. Weir MR , Salomon DR, Cohen DJ, Carpenter CB. Lack of secondary suppressor response in enhanced
allografted rats with endogenous suppressor activity in spleen and diminished cytotoxic T cell response. Transplantation 1988;46:731739. 17. Weir MR , Shen SY, Dagher FJ, Bentley FR, Lesko LJ, Sadler JH. Effects of allostimulation and cyclosporine therapy on cytotoxic antibody production in highly sensitized prospective renal transplant recipients. Transplantation 1988;46:591594. 18. Shen SY, Weir MR, Coughlin TR. Renal allograft biopsy and conversion from cyclosporine to azathioprine. Transplantation 1989;47:223229. 19. Weir MR, Klassen DK, Hoover N, Douglas FL. Preliminary observations of the acute effects of selective serum /thromboxane inhibition and angiotensin converting enzyme inhibition on blood pressure and renal hemodynamics in hypertensive humans. J Clin Pharmacol 1989;29:11081116. 20. Weir MR, Vlachkis ND, DeQuattro V, Douglas J, Svetkey LP, Singh S, Wiedl SC, Chen CF, Woodward DL, Saunders E. Evaluation of the clinical pharmacology of nilvadipine in patients with mild to moderate essential hypertension. J Clin Pharmacol 1990;30:425437. 21. Burris JF, Weir MR, Oparil S, Weber M, Cady WJ. An innovative approach to clinical trials of combination therapy: multifactorial assessment of diltiazem and hydrochlorothiazide in hypertension. JAMA 1990;263:15071512. 22. Burris JF, Weir MR, Oparil S, Weber M, Cady WJ, Stewart WH. An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapy. Comment in: JAMA 1990;264:971973. 23. Saunders E, Weir MR, Kong BW, et al. A comparison of the efficacy and safety of a blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med 1990;150:17071713. 24. Croog SH, Kong BW, Levine S, Weir MR, Baume RM, Saunders E. Hypertensive black men and women. Quality of life and effects of antihypertensive medications. Black Hypertension Quality of Life Multicenter Trial Group. Arch Intern Med 1990;150:17331741. 25. Weir MR, Klassen DK, Shen SY, Sullivan D, Buddemeyer EU, Handwerger BS. Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics, and urine prostaglandin production of healthy humans. Transplantation 1990;49:4147. 26. Plaisance KI, Drusano GL, Forrest A, Weir MR, Standiford HC. Effect of renal function on the bioavailability of ciprofloxacin. Antimicrobial Agents and Chemotherapy 1990;34:10311034. 27. Weir MR . Calcium channel blockers in organ transplantation: Important new therapeutic modalities. J Am Soc Nephrol 1990;1:S28S38. 28. Li XW, Weir MR. Radix Tripterygium Wilfordii–a Chinese herbal medicine with potent immunosuppressive properties. Transplantation 1990;50:8286. 29. Gottlieb SS, Weir MR. Renal effects of angiotensinconverting enzyme inhibition in congestive heart failure. Am J Cardiol 1990;66:14D20D; discussion 20D21D. 30. Weir MR, Peppler R, Gomolka D, Handwerger BS. Additive inhibition of afferent and efferent immunological responses of human peripheral blood mononuclear cells by verapamil and cyclosporine. Transplantation 1991;51:851857 31. Weir MR, Josselson J, Ekelund LG, Korc M, Pool JL, Stein GH, Wohlbach RA, Champion D. Nicardipine as antihypertensive monotherapy: positive effects on quality of life. J Hum Hypertens 1991;5:205213. 32. Weir MR, Klassen DK, Hall PS, Schubert C, Voss TE, Stromatt SC, Brown JA. Minimization of indomethacininduced reduction in renal function by misoprostol. J Clin Pharm 1991;31:729735. 33. Muluk SC, Clerici M, Via CS, Weir MR, Kimmel PL, Shearer GM. Correlation of in vitro CD4+ T helper cell function with clinical graft status in immunosuppressed kidney transplant recipients. Transplantation 1991;52:284291. 34. Weir MR Impact of age, race, and obesity on hypertensive mechanisms and therapy. Am J Med 1991;90(5A):3S14S. 35. Weir MR. Therapeutic benefits of calcium channel blockers in cyclosporinetreated organ transplant recipients: blood pressure control and immunosuppression. Am J Med 1991; 90(5A):32S36S.